CN113116795A - A cosmetic composition for stimulating collagen production and resisting wrinkle - Google Patents
A cosmetic composition for stimulating collagen production and resisting wrinkle Download PDFInfo
- Publication number
- CN113116795A CN113116795A CN202110294315.1A CN202110294315A CN113116795A CN 113116795 A CN113116795 A CN 113116795A CN 202110294315 A CN202110294315 A CN 202110294315A CN 113116795 A CN113116795 A CN 113116795A
- Authority
- CN
- China
- Prior art keywords
- parts
- mixing
- temperature
- solution
- mixed solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 239000002537 cosmetic Substances 0.000 title claims abstract description 32
- 230000037303 wrinkles Effects 0.000 title claims abstract description 26
- 230000004936 stimulating effect Effects 0.000 title claims abstract description 23
- 230000037319 collagen production Effects 0.000 title claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 48
- 238000003756 stirring Methods 0.000 claims abstract description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 25
- 108010035532 Collagen Proteins 0.000 claims abstract description 25
- 229920001436 collagen Polymers 0.000 claims abstract description 25
- 239000000419 plant extract Substances 0.000 claims abstract description 21
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 20
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 20
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 19
- 238000010438 heat treatment Methods 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000008367 deionised water Substances 0.000 claims abstract description 14
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- ZJSJQWDXAYNLNS-UHFFFAOYSA-N (+) pinoresinol-4,4'-di-O-beta-D-glucopyranoside Natural products COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC4C(C(O)C(O)C(CO)O4)O)=CC=3)CO2)=CC=C1OC1OC(CO)C(O)C(O)C1O ZJSJQWDXAYNLNS-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZJSJQWDXAYNLNS-FUPWJLLWSA-N (2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)CO2)=CC=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZJSJQWDXAYNLNS-FUPWJLLWSA-N 0.000 claims abstract description 11
- YDSVPIYLRFZLAT-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N Chemical compound C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N YDSVPIYLRFZLAT-UHFFFAOYSA-N 0.000 claims abstract description 11
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 11
- 238000001816 cooling Methods 0.000 claims abstract description 11
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 11
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 10
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 10
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 10
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 10
- 241001116389 Aloe Species 0.000 claims abstract description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 3
- -1 octyl glycol Chemical compound 0.000 claims abstract description 3
- 239000011259 mixed solution Substances 0.000 claims description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- 239000007787 solid Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 18
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 229920001661 Chitosan Polymers 0.000 claims description 12
- 239000008055 phosphate buffer solution Substances 0.000 claims description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 10
- 239000002211 L-ascorbic acid Substances 0.000 claims description 10
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012065 filter cake Substances 0.000 claims description 9
- 238000003828 vacuum filtration Methods 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 6
- 229940106681 chloroacetic acid Drugs 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 5
- 240000009088 Fragaria x ananassa Species 0.000 claims description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 240000007890 Leonurus cardiaca Species 0.000 claims description 3
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 3
- 108060008539 Transglutaminase Proteins 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 239000005457 ice water Substances 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 102000003601 transglutaminase Human genes 0.000 claims description 3
- 239000012856 weighed raw material Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 8
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 244000144927 Aloe barbadensis Species 0.000 description 5
- 235000002961 Aloe barbadensis Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009127 Glutaminase Human genes 0.000 description 1
- 108010073324 Glutaminase Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a cosmetic composition for stimulating collagen to generate and resisting wrinkles, which comprises the following raw materials in parts by weight: 0.6-0.8 part of pinoresinol diglucoside, 1-3 parts of dipeptide diaminobutyrylbenzyl amide diacetate, 2-4 parts of sodium hyaluronate, 100 parts of deionized water, 3-5 parts of glycerol, 10-12 parts of aloe gel, 50-70 parts of plant extract, 2-4 parts of octyl glycol, 1-3 parts of 1, 2-hexanediol, 1.6-2 parts of palmitoyl tripeptide and 3-6 parts of a moisturizing antioxidant; the cosmetic composition for stimulating collagen production and resisting wrinkles is prepared by the following steps: the first step, preparing a first component; step two, preparing a second component; and thirdly, respectively heating the first component and the second component, then mixing, cooling, adding palmitoyl tripeptide, a moisturizing antioxidant, and uniformly stirring to obtain the cosmetic composition for stimulating the generation of collagen and resisting wrinkles.
Description
Technical Field
The invention belongs to the technical field of cosmetic compositions, and particularly relates to a cosmetic composition for stimulating collagen to generate and resisting wrinkles.
Background
There is an increasing need in the cosmetics industry to develop products that can be topically applied to the skin to improve the condition and appearance of the skin. Consumer interest is in reducing or delaying the dermatological signs of chronologically or hormonally aged or photoaged skin, such as fine lines, wrinkles and sagging skin and other conditions resulting from the progressive degradation of the dermal-epidermal junction and cell-cell adhesion in the epidermis. During the aging process, the appearance of skin, i.e., the color and appearance of skin, deteriorates slowly from aging and/or exposure to sunlight. A number of cosmetic and medical treatments have been developed in an attempt to treat aging or aged skin. Such cosmetics or treatment methods typically contain an organic acid as its active ingredient or ingredient. These active ingredients often cause consumer discomfort such as burning, itching and redness.
Thus, there is still a general need in the cosmetics industry for products that retard or counteract the effects of aging of the skin. In particular, there remains a need for topically applied cosmetic compositions using natural plant materials as active ingredients that have anti-aging and skin texture benefits.
Disclosure of Invention
The present invention provides a cosmetic composition for stimulating collagen production to resist wrinkles.
The technical problems to be solved by the invention are as follows:
a large number of cosmetic and medical treatments are currently being developed in an attempt to treat aging or already aging skin. Such cosmetics or treatment methods typically contain an organic acid as its active ingredient or ingredient. These active ingredients often cause consumer discomfort such as burning, itching and redness.
The purpose of the invention can be realized by the following technical scheme:
a cosmetic composition for stimulating collagen generation and resisting wrinkles comprises the following raw materials in parts by weight:
0.6-0.8 part of pinoresinol diglucoside, 1-3 parts of dipeptide diaminobutyrylbenzyl amide diacetate, 2-4 parts of sodium hyaluronate, 100 parts of deionized water, 3-5 parts of glycerol, 10-12 parts of aloe gel, 50-70 parts of plant extract, 2-4 parts of octyl glycol, 1-3 parts of 1, 2-hexanediol, 1.6-2 parts of palmitoyl tripeptide and 3-6 parts of a moisturizing antioxidant;
the cosmetic composition for stimulating collagen production and resisting wrinkles is prepared by the following steps:
firstly, adding pinoresinol diglucoside, dipeptide diaminobutyryl benzylamide diacetate and sodium hyaluronate into deionized water, uniformly mixing, heating to 80-85 ℃, preserving heat, stirring and uniformly dispersing; regulating the pH value of the solution to 5.5 by using triethanolamine to obtain a first mixture;
secondly, mixing glycerol, aloe vera gel, plant extract, caprylyl glycol and 1, 2-hexanediol, and uniformly stirring at 40 ℃ to obtain a second mixture;
and step three, respectively heating the first mixture and the second mixture to 80 ℃, mixing and stirring at the rotating speed of 100r/min, cooling to 45 ℃, adding palmitoyl tripeptide and a moisturizing antioxidant, uniformly stirring, and storing at 25 ℃ to obtain the cosmetic composition for stimulating the generation of collagen and resisting wrinkles.
Further, the moisturizing antioxidant is prepared by the following steps:
step S11, mixing a sodium hydroxide solution and chitosan, standing for 10-12h at the temperature of-18 ℃ after mixing, then unfreezing and transferring to a three-neck flask, adding isopropanol into the three-neck flask, stirring for 30-40min at the temperature of 25 ℃ and the rotation speed of 400r/min, adding solid chloroacetic acid in an equivalent manner for three times, wherein the addition time is 5min, stirring and reacting for 2h at the temperature of 70 ℃ and the stirring speed of 400r/min, after the reaction is finished, adding equal-volume distilled water into the solution for diluting, adjusting the pH value to 7.0 by glacial acetic acid, carrying out vacuum filtration, washing a filter cake by using an ethanol aqueous solution with a volume fraction of 70% and absolute ethanol in sequence, and after the washing is finished, putting into a 60 ℃ drying oven for drying to obtain a solid a;
step S12, adding the solid a and N, N-dimethylformamide into a round-bottom flask, adding pyridine, setting the temperature to be 0-5 ℃, continuously stirring for 30min at the rotation speed of 300r/min, dropwise adding thionyl chloride mixed solution by using a constant-pressure dropping funnel, heating to 75 ℃ after dropwise adding, continuously stirring for reacting for 3h, mixing the obtained reaction solution with anhydrous ether with the same volume after the reaction is finished, separating out a precipitate, carrying out vacuum filtration, washing the obtained filter cake with acetone until the filtrate does not contain chloride ions, and after the washing is finished, carrying out vacuum drying at 50 ℃ to constant weight to obtain a solid b;
step S13, mixing solid b and phosphate buffer solution according to 1 g: mixing 50mL to obtain a mixed solution A, and mixing collagen peptide phosphate and a phosphate buffer solution according to the weight ratio of 1 g: 50mL of the mixture was mixed to obtain a mixed solution B, and the mixture was mixed with a microbial transglutaminase and a phosphate buffer solution in an amount of 0.1 g: mixing 20mL of the mixture to obtain a mixed solution C, mixing the mixed solution A, the mixed solution B and the mixed solution C, stirring for 10min at the temperature of 100 ℃, then cooling to room temperature, carrying out vacuum filtration, and carrying out vacuum drying on the obtained filter cake at the temperature of 25 ℃ to constant weight to obtain a first component;
further, in step S11, the sodium hydroxide solution is sodium hydroxide and deionized water, and the ratio of 1 g: 1mL of the sodium hydroxide solution and the chitosan are mixed, and the dosage ratio of the sodium hydroxide solution to the chitosan is 10 g: 10 mL; the dosage ratio of the chitosan, the isopropanol and the chloroacetic acid is 1 g: 10-15 mL: 1.2 g.
Further, in the step S12, the thionyl chloride mixed solution is thionyl chloride and N, N-dimethylformamide according to a volume ratio of 1: 1, mixing; the dosage ratio of the solid a, the N, N-dimethylformamide, the pyridine and the thionyl chloride mixed solution is 1 g: 5mL of: 5mL of: 20-30 mL.
Further, the phosphate buffer solution in step S13 is a 0.2mol/L Na2HPO4/NaH2PO4 buffer solution, and the pH value of the buffer solution is 6; the volume ratio of the mixed liquor A to the mixed liquor B to the mixed liquor C is 5: 5: 2.
step S21, adding dimethylacetamide into a three-neck flask, adding L-ascorbic acid and dichloromethane under the conditions that the temperature is 0 ℃ and the rotating speed is 200r/min, stirring for 6-10min, adding solid b for three times in different quantities, keeping the temperature and the rotating speed constant, continuing stirring for 50-60min, washing the obtained reaction solution with ethyl acetate at 0 ℃, washing with ice water until the filtrate does not contain chloride ions, after washing, drying in vacuum at 25 ℃ to constant weight to obtain a second component, mixing the first component and the second component according to a mass ratio of 1: 1 mixing to obtain the moisture-preserving antioxidant.
Further, the amount ratio of dimethylacetamide, L-ascorbic acid, dichloromethane and solid b in step S21 was 6 mL: 1 g: 2-3 mL: 1-1.2 g.
Further, the plant extract is prepared by the following steps:
step A11, weighing the following raw materials in parts by weight: 50-60 parts of strawberry leaves, 10-20 parts of angelica, 10-26 parts of pseudo-ginseng, 10-16 parts of motherwort, 10-20 parts of radix ophiopogonis and 10-15 parts of liquorice;
step A12, mixing the weighed raw materials, adding the mixture into a water-alcohol mixed solution, heating the mixture to 75-90 ℃, and extracting for 30-120 min;
step A13, stopping heating, cooling to 20-50 deg.C, filtering, concentrating under reduced pressure to remove solvent, and making into plant extract.
Further, in the step a12, the water-alcohol mixed solution is deionized water and propylene glycol according to a volume ratio of 2: 0.6-1 by weight; the dosage ratio of the weighed total amount of the raw materials to the water-alcohol mixed solution is 0.6-1 g: 20-30 mL.
The invention has the beneficial effects that:
the pinoresinol diglucoside in the first component can improve the proliferation activity of fibroblasts, promote the expression of related collagen, inhibit the expression of matrix metalloproteinases and reduce the degradation of collagen, and has a structure similar to that of estrogen and an estrogen-like effect. The phytoestrogen has the functions of promoting epidermal proliferation and collagen synthesis in vitro, protecting collagen from enzyme degradation, and promoting skin cells to generate collagen, thereby realizing skin repair and reducing wrinkle. Dipeptide diaminobutyrylbenzylamide diacetate is a synthetic peptide simulating snake venom serum, and can prevent acetylcholine nerve conduction, achieve the effect of relaxing muscles, and further improve dynamic wrinkles. The plant extract contains strawberry leaf extract, the strawberry leaf extract contains effective components for promoting fibroblast secretion and maturation, and the effective components cooperate with traditional Chinese medicine raw materials to protect skin.
Using chitosan with good biocompatibility as a matrix, firstly alkalifying the chitosan, then adding chloroacetic acid for many times for carboxymethylation to obtain a solid a, and performing acyl chlorination on the solid a to obtain a solid b; the solid b and the collagen peptide form isopeptide between primary amine on the solid b and amino on the collagen peptide under the catalytic action of glutaminase, the collagen peptide is grafted to chitosan, and the collagen peptide has stronger free radicals and excellent inoxidizability, and simultaneously can stimulate cell proliferation, stimulate collagen synthesis of skin cells and have moisturizing effect.
Solid b and the enol-type hydroxyl on the L-ascorbic acid are subjected to esterification reaction to prepare a second component, L-ascorbic acid is called vitamin C for short, the L-ascorbic acid is not only applied to the fields of food, agriculture and the like, but also applied to medical cosmetology, but 2 adjacent enol-type hydroxyl on C2 and C3 in the molecular structure of the L-ascorbic acid are extremely easy to decompose, and the properties of the L-ascorbic acid can be changed and limited by external influences.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The moisturizing antioxidant is prepared by the following steps:
step S11, mixing a sodium hydroxide solution and chitosan, standing for 11h at the temperature of-18 ℃ after mixing, then unfreezing and transferring to a three-neck flask, adding isopropanol into the three-neck flask, stirring for 35min at the temperature of 25 ℃ and the rotating speed of 400r/min, adding solid chloroacetic acid in three equal amounts, each time at an interval of 5min, stirring for reaction for 2h at the temperature of 70 ℃ and the stirring speed of 400r/min, after the reaction is finished, adding equal-volume distilled water into the solution for dilution, adjusting the pH value to 7.0 with glacial acetic acid, carrying out vacuum filtration, washing a filter cake with an ethanol aqueous solution with a volume fraction of 70% and absolute ethanol in sequence, and after the washing is finished, putting into a 60 ℃ oven for drying to obtain a solid a;
step S12, adding the solid a and N, N-dimethylformamide into a round-bottom flask, adding pyridine, setting the temperature at 2 ℃ and the rotating speed at 300r/min, continuing stirring for 30min, dropwise adding thionyl chloride mixed solution by using a constant-pressure dropping funnel, heating to 75 ℃ after dropwise adding, continuing stirring for reaction for 3h, after the reaction is finished, mixing the obtained reaction solution with equal volume of anhydrous ether, separating out a precipitate, performing vacuum filtration, washing the obtained filter cake with acetone until the filtrate does not contain chloride ions, and after the washing is finished, performing vacuum drying at 50 ℃ to constant weight to obtain a solid b;
step S13, mixing solid b and phosphate buffer solution according to 1 g: mixing 50mL to obtain a mixed solution A, and mixing collagen peptide phosphate and a phosphate buffer solution according to the weight ratio of 1 g: 50mL of the mixture was mixed to obtain a mixed solution B, and the mixture was mixed with a microbial transglutaminase and a phosphate buffer solution in an amount of 0.1 g: mixing 20mL of the mixture to obtain a mixed solution C, mixing the mixed solution A, the mixed solution B and the mixed solution C, stirring for 10min at the temperature of 100 ℃, then cooling to room temperature, carrying out vacuum filtration, and carrying out vacuum drying on the obtained filter cake at the temperature of 25 ℃ to constant weight to obtain a first component.
Wherein the sodium hydroxide solution in step S11 is sodium hydroxide and deionized water in a ratio of 1 g: 1mL of the sodium hydroxide solution and the chitosan are mixed, and the dosage ratio of the sodium hydroxide solution to the chitosan is 10 g: 10 mL; the dosage ratio of the chitosan, the isopropanol and the chloroacetic acid is 1 g: 12mL of: 1.2 g;
wherein the thionyl chloride mixed solution in the step S12 is thionyl chloride and N, N-dimethylformamide in a volume ratio of 1: 1, mixing; the dosage ratio of the solid a, the N, N-dimethylformamide, the pyridine and the thionyl chloride mixed solution is 1 g: 5mL of: 5mL of: 25 mL;
wherein the phosphate buffer solution in the step S13 is 0.2mol/L Na2HPO4/NaH2PO4 buffer solution, and the volume ratio of the mixed solution A to the mixed solution B to the mixed solution C is 5: 5: 2.
step S21, adding dimethylacetamide into a three-neck flask, adding L-ascorbic acid and dichloromethane under the conditions that the temperature is 0 ℃ and the rotating speed is 200r/min, stirring for 8min, adding solid b for three times in different quantities, keeping the temperature and the rotating speed constant, continuing stirring for 55min, washing the obtained reaction solution with ethyl acetate at 0 ℃, washing with ice water until the filtrate does not contain chloride ions, after washing, drying in vacuum at 25 ℃ to constant weight to obtain a second component, and mixing the first component and the second component according to a mass ratio of 1: 1 mixing to obtain the moisture-preserving antioxidant.
Wherein the dosage ratio of the dimethylacetamide, the L-ascorbic acid, the dichloromethane and the solid b in the step S21 is 6 mL: 1 g: 2.5 mL: 1g of the total weight of the composition.
Example 2
The plant extract is prepared by the following steps:
step A11, weighing the following raw materials in parts by weight: 55 parts of strawberry leaves, 15 parts of angelica, 18 parts of pseudo-ginseng, 13 parts of motherwort, 15 parts of radix ophiopogonis and 2 parts of liquorice;
step A12, mixing the weighed raw materials, adding the mixture into a water-alcohol mixed solution, heating to 82 ℃ and extracting for 65 min;
and step A13, stopping heating, cooling to 35 ℃, filtering, concentrating under reduced pressure, and removing the solvent to obtain the plant extract.
Wherein, the water-alcohol mixed solution in the step A12 is deionized water and propylene glycol according to the volume ratio of 2: 0.8, mixing; the ratio of the total amount of the raw materials to the amount of the water-alcohol mixed solution is 0.8 g: 25 mL.
Example 3
A cosmetic composition for stimulating collagen generation and resisting wrinkles comprises the following raw materials in parts by weight:
0.6 part of pinoresinol diglucoside, 1 part of dipeptide diaminobutyrylbenzylamide diacetate, 2 parts of sodium hyaluronate, 100 parts of deionized water, 3 parts of glycerol, 10 parts of aloe gel, 50 parts of plant extract, 2 parts of caprylyl glycol, 1 part of 1, 2-hexanediol, 1.6 parts of palmitoyl tripeptide and 3 parts of a moisturizing antioxidant;
the cosmetic composition for stimulating collagen production and resisting wrinkles is prepared by the following steps:
firstly, adding pinoresinol diglucoside, dipeptide diaminobutyryl benzylamide diacetate and sodium hyaluronate into deionized water, uniformly mixing, heating to 80 ℃, preserving heat, stirring and uniformly dispersing; regulating the pH value of the solution to 5.5 by using triethanolamine to obtain a first mixture;
secondly, mixing glycerol, aloe vera gel, plant extract, caprylyl glycol and 1, 2-hexanediol, and uniformly stirring at 40 ℃ to obtain a second mixture;
and step three, respectively heating the first mixture and the second mixture to 80 ℃, mixing and stirring at the rotating speed of 100r/min, cooling to 45 ℃, adding palmitoyl tripeptide and a moisturizing antioxidant, uniformly stirring, and storing at 25 ℃ to obtain the cosmetic composition for stimulating the generation of collagen and resisting wrinkles.
Wherein the moisturizing antioxidant was prepared as in example 1; the plant extract was prepared as in example 2.
Example 4
A cosmetic composition for stimulating collagen generation and resisting wrinkles comprises the following raw materials in parts by weight:
0.7 part of pinoresinol diglucoside, 2 parts of dipeptide diaminobutyrylbenzylamide diacetate, 3 parts of sodium hyaluronate, 150 parts of deionized water, 4 parts of glycerol, 11 parts of aloe vera gel, 60 parts of plant extract, 3 parts of caprylyl glycol, 2 parts of 1, 2-hexanediol, 1.8 parts of palmitoyl tripeptide and 4 parts of moisturizing antioxidant;
the cosmetic composition for stimulating collagen production and resisting wrinkles is prepared by the following steps:
firstly, adding pinoresinol diglucoside, dipeptide diaminobutyryl benzylamide diacetate and sodium hyaluronate into deionized water, uniformly mixing, heating to 82 ℃, preserving heat, stirring and uniformly dispersing; regulating the pH value of the solution to 5.5 by using triethanolamine to obtain a first mixture;
secondly, mixing glycerol, aloe vera gel, plant extract, caprylyl glycol and 1, 2-hexanediol, and uniformly stirring at 40 ℃ to obtain a second mixture;
and step three, respectively heating the first mixture and the second mixture to 80 ℃, mixing and stirring at the rotating speed of 100r/min, cooling to 45 ℃, adding palmitoyl tripeptide and a moisturizing antioxidant, uniformly stirring, and storing at 25 ℃ to obtain the cosmetic composition for stimulating the generation of collagen and resisting wrinkles.
Wherein the moisturizing antioxidant was prepared as in example 1; the plant extract was prepared as in example 2.
Example 5
A cosmetic composition for stimulating collagen generation and resisting wrinkles comprises the following raw materials in parts by weight:
0.8 part of pinoresinol diglucoside, 3 parts of dipeptide diaminobutyrylbenzylamide diacetate, 4 parts of sodium hyaluronate, 200 parts of deionized water, 5 parts of glycerol, 12 parts of aloe gel, 70 parts of plant extract, 4 parts of caprylyl glycol, 3 parts of 1, 2-hexanediol, 2 parts of palmitoyl tripeptide and 6 parts of a moisturizing antioxidant;
the cosmetic composition for stimulating collagen production and resisting wrinkles is prepared by the following steps:
firstly, adding 0.8 part of pinoresinol diglucoside, dipeptide diaminobutyrylbenzyl amide diacetate and sodium hyaluronate into deionized water, uniformly mixing, heating to 85 ℃, preserving heat, stirring and uniformly dispersing; regulating the pH value of the solution to 5.5 by using triethanolamine to obtain a first mixture;
secondly, mixing glycerol, aloe vera gel, plant extract, caprylyl glycol and 1, 2-hexanediol, and uniformly stirring at 40 ℃ to obtain a second mixture;
and step three, respectively heating the first mixture and the second mixture to 80 ℃, mixing and stirring at the rotating speed of 100r/min, cooling to 45 ℃, adding palmitoyl tripeptide and a moisturizing antioxidant, uniformly stirring, and storing at 25 ℃ to obtain the cosmetic composition for stimulating the generation of collagen and resisting wrinkles.
Wherein the moisturizing antioxidant was prepared as in example 1; the plant extract was prepared as in example 2.
Comparative example 1
The moisture-retaining antioxidant was not added, and the remaining raw materials and preparation process were the same as in example 3.
Comparative example 2
The plant extracts were not added, and the rest of the raw materials and the preparation process were the same as in example 3.
The cosmetic compositions of examples 1 to 3 and comparative examples 1 to 2 were tested;
testing the water content: 50 volunteers, divided into 5 groups, marked 4X 4cm inside the forearm of the left and right hand2Test area, same arm mark 2 areas simultaneously, the interval of area is 2 cm. The test and control areas were measured using a skin moisture test probe assay, 3 replicates per area. The blank value of each test area was measured and then measured at 2.0. + -. 0.1mg sample/cm2The amount of (a) was applied to the test area uniformly using a latex finger cuff. Applying for 14 days and 28 days, respectively, and measuring the skin moisture content of the tested area relative to the blank control area by using a skin moisture test probe;
thin test of desalination: the using method comprises the following steps: the external application is carried out for 2 times every day, the application amount is that the face is evenly coated, and the fine line condition is observed. 50 volunteers, divided into 5 groups; the results are shown in table 1 below:
TABLE 1
As can be seen from table 1 above, the cosmetic composition for stimulating collagen production and resisting wrinkles prepared by the present invention has excellent moisturizing performance and a significant effect of reducing fine lines.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing is illustrative and explanatory only and is not intended to be exhaustive or to limit the invention to the precise embodiments described, and various modifications, additions, and substitutions may be made by those skilled in the art without departing from the scope of the invention or exceeding the scope of the claims.
Claims (3)
1. A cosmetic composition for stimulating collagen to generate and resisting wrinkles is characterized by comprising the following raw materials in parts by weight:
0.6-0.8 part of pinoresinol diglucoside, 1-3 parts of dipeptide diaminobutyrylbenzyl amide diacetate, 2-4 parts of sodium hyaluronate, 100 parts of deionized water, 3-5 parts of glycerol, 10-12 parts of aloe gel, 50-70 parts of plant extract, 2-4 parts of octyl glycol, 1-3 parts of 1, 2-hexanediol, 1.6-2 parts of palmitoyl tripeptide and 3-6 parts of a moisturizing antioxidant;
the moisturizing antioxidant is prepared from a first component and a second component in a mass ratio of 1: 1, mixing;
the first component is prepared by the following steps:
step S11, mixing a sodium hydroxide solution and chitosan, standing for 10-12h at the temperature of-18 ℃ after mixing, then unfreezing and transferring to a three-neck flask, adding isopropanol into the three-neck flask, stirring for 30-40min at the temperature of 25 ℃, adding chloroacetic acid in an equivalent manner for three times, with an interval of 5min each time, stirring and reacting for 2h at the temperature of 70 ℃, adding equal volume of distilled water into the solution after the reaction is finished, diluting the solution, adjusting the pH value to 7.0 by glacial acetic acid, carrying out vacuum filtration, washing a filter cake by an ethanol aqueous solution with a volume fraction of 70% and absolute ethanol in sequence, and drying in a 60 ℃ oven after the washing is finished to obtain a solid a;
step S12, adding the solid a and N, N-dimethylformamide into a round-bottom flask, adding pyridine, continuously stirring for 30min at the temperature of 0-5 ℃, dropwise adding thionyl chloride mixed solution by using a constant-pressure dropping funnel, heating to 75 ℃ after dropwise adding, continuously stirring for reacting for 3h, mixing the obtained reaction solution with anhydrous ether with the same volume after the reaction is finished, separating out a precipitate, carrying out vacuum filtration, washing the obtained filter cake with acetone until the filtrate does not contain chloride ions, and after the washing is finished, carrying out vacuum drying at 50 ℃ to constant weight to obtain a solid b;
step S13, mixing solid b and phosphate buffer solution according to 1 g: mixing 50mL to obtain a mixed solution A, and mixing collagen peptide phosphate and a phosphate buffer solution according to the weight ratio of 1 g: 50mL of the mixture was mixed to obtain a mixed solution B, and the mixture was mixed with a microbial transglutaminase and a phosphate buffer solution in an amount of 0.1 g: mixing 20mL of the mixture to obtain a mixed solution C, mixing the mixed solution A, the mixed solution B and the mixed solution C, stirring for 10min at the temperature of 100 ℃, then cooling to room temperature, carrying out vacuum filtration, and carrying out vacuum drying on the obtained filter cake at the temperature of 25 ℃ to constant weight to obtain a first component.
2. The cosmetic composition for stimulating collagen production to combat wrinkles as claimed in claim 1 wherein the second component is prepared by the steps of:
step S21, adding dimethylacetamide into a three-neck flask, adding L-ascorbic acid and dichloromethane at the temperature of 0 ℃, stirring for 6-10min, adding solid b in different quantities for three times, keeping the temperature and the rotating speed unchanged, continuously stirring for 50-60min, washing the obtained reaction solution with ethyl acetate at the temperature of 0 ℃, washing with ice water until the filtrate does not contain chloride ions, and after washing, drying in vacuum at the temperature of 25 ℃ to constant weight to obtain a second component.
3. The cosmetic composition for stimulating collagen production to combat wrinkles as claimed in claim 1, wherein the plant extract is prepared by the steps of:
step A11, weighing the following raw materials in parts by weight: 50-60 parts of strawberry leaves, 10-20 parts of angelica, 10-26 parts of pseudo-ginseng, 10-16 parts of motherwort, 10-20 parts of radix ophiopogonis and 10-15 parts of liquorice;
step A12, mixing the weighed raw materials, adding the mixture into a water-alcohol mixed solution, heating the mixture to 75-90 ℃, and extracting for 30-120 min;
step A13, stopping heating, cooling to 20-50 deg.C, filtering, concentrating under reduced pressure to remove solvent, and making into plant extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110294315.1A CN113116795A (en) | 2021-03-19 | 2021-03-19 | A cosmetic composition for stimulating collagen production and resisting wrinkle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110294315.1A CN113116795A (en) | 2021-03-19 | 2021-03-19 | A cosmetic composition for stimulating collagen production and resisting wrinkle |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113116795A true CN113116795A (en) | 2021-07-16 |
Family
ID=76773441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110294315.1A Pending CN113116795A (en) | 2021-03-19 | 2021-03-19 | A cosmetic composition for stimulating collagen production and resisting wrinkle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113116795A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038385A (en) * | 2016-06-08 | 2016-10-26 | 广州市创美时美容化妆品有限公司 | Cosmetic composition capable of stimulating collagen generation for wrinkle resistance |
US20190054036A1 (en) * | 2017-08-17 | 2019-02-21 | Nanofiber Solutions, Inc. | Electrospun fibers having a pharmaceutical and methods of making and using the same |
CN110191895A (en) * | 2016-11-30 | 2019-08-30 | 路博润先进材料公司 | Compounds useful in the treatment and/or care of skin, hair, nails and/or mucous membranes |
CN110812318A (en) * | 2019-11-18 | 2020-02-21 | 诺恩诺德医学研究院(北京)有限公司 | Method for preparing optimized fibroblast extract for cosmetic raw material |
-
2021
- 2021-03-19 CN CN202110294315.1A patent/CN113116795A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038385A (en) * | 2016-06-08 | 2016-10-26 | 广州市创美时美容化妆品有限公司 | Cosmetic composition capable of stimulating collagen generation for wrinkle resistance |
CN110191895A (en) * | 2016-11-30 | 2019-08-30 | 路博润先进材料公司 | Compounds useful in the treatment and/or care of skin, hair, nails and/or mucous membranes |
US20190054036A1 (en) * | 2017-08-17 | 2019-02-21 | Nanofiber Solutions, Inc. | Electrospun fibers having a pharmaceutical and methods of making and using the same |
CN110812318A (en) * | 2019-11-18 | 2020-02-21 | 诺恩诺德医学研究院(北京)有限公司 | Method for preparing optimized fibroblast extract for cosmetic raw material |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013176435A1 (en) | Anti-ageing composition containing dehydrogenated abietic acid as active ingredient | |
KR20140126892A (en) | External composition for skin containing Ginsenoside Rg3 | |
CN112972333B (en) | Whitening and moisturizing mask liquid containing paeonia lactiflora root extract and preparation method thereof | |
CN113768819A (en) | A kind of preparation method of moisturizing anti-aging cosmetic composition containing cationic hyaluronic acid | |
CN113491651A (en) | Soothing and repairing mask essence containing camellia extract and preparation method and application thereof | |
CN117159403A (en) | Oil-control fluffy composition and preparation method and application thereof | |
CN109077971B (en) | A kind of preparation method of fermented soybean milk and its application in cosmetics | |
CN107440996A (en) | A kind of skin care item containing B B-complex and preparation method thereof | |
CN113116795A (en) | A cosmetic composition for stimulating collagen production and resisting wrinkle | |
CN118045020A (en) | Alopecia preventing composition and preparation method and application thereof | |
CN112778439B (en) | Whitening skin care product and preparation method thereof | |
CN115919716A (en) | Low-irritation, whitening and skin-care facial mask and preparation method thereof | |
CN114920805A (en) | Novel scorpion venom having wrinkle-improving activity and composition comprising the same | |
CN115364020A (en) | A whitening and moisturizing composition, body lotion and preparation method thereof | |
CN113208947A (en) | Anti-aging moisturizing composition and application thereof | |
KR20210146788A (en) | Cosmetic composition comprising fermentation ingredients | |
CN114533642A (en) | Composition for tightening and brightening skin and preparation method thereof | |
CN111388377A (en) | Nicotinamide stock solution and preparation method thereof | |
CN113101261A (en) | Skin anti-aging composition and preparation method and application thereof | |
CN111297767A (en) | Whitening composition and skin care product containing same | |
CN115844742B (en) | Moisturizing composition, preparation method thereof and cosmetic | |
CN116549316B (en) | Composition containing blue copper peptide freeze-dried powder and application of composition in cosmetics | |
CN118178296B (en) | Preparation method and application of firming and anti-wrinkle plant composition | |
CN114437242B (en) | Usnic polysaccharide, preparation method and application thereof | |
CN115844805B (en) | Whitening essence for inhibiting tyrosinase activity by secondarily fermenting micro-molecular sodium hyaluronate Supferm HA and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210716 |